A decade of research in Taiwan is reshaping how pancreatic cancer is detected and treated, combining innovative therapies with breakthrough AI diagnostics. These advances are opening new possibilities for earlier intervention and longer survival.
Kris Hager reflects on BMS’s 60-year legacy in Taiwan and shares how integrity, inclusivity, and cross-sector collaboration shape his leadership approach and the company’s vision for driving better outcomes in Taiwan’s evolving healthcare landscape.
By expanding local R&D, advancing precision health, and advocating for a stronger innovation ecosystem, Roche Taiwan emphasizes its long-term commitment to helping Taiwan build a resilient, globally aligned healthcare system.
Chang Gung Memorial Hospital is redefining healthcare in Taiwan through AI-driven innovation, sustainable practices, and global collaboration. By integrating research, technology, and social responsibility, it aims to build a smarter, greener, and more inclusive healthcare system for future generations.
Taiwan’s healthcare strengths, tech know-how, and investor support are driving a fast-growing MedTech ecosystem. Startups in digital health, AI diagnostics, and connected care are finding Taiwan an ideal gateway to Asia.
Taiwan faces a turning point in diabetes care, balancing global breakthroughs and digital health tools with local challenges in reimbursement, stigma, and access, positioning itself to lead the region in next-generation treatment.
With structural heart disease on the rise, Edwards Lifesciences urges earlier intervention, broader access, and updated policies to help Taiwan lead in advanced cardiovascular care.
Roche Taiwan is advancing personalized healthcare and driving medical innovation through strong public-private partnerships, sustainable practices, and a deep commitment to patient well-being. With pioneering work in diagnostics, oncology, and ophthalmology, the company continues to shape a healthier future for Taiwan.
Johnson & Johnson Taiwan is advancing healthcare through groundbreaking innovations in medicine and MedTech, while championing faster access, patient-centered care, and workforce development. From oncology and neuroscience to AI-powered surgery, the company is redefining what’s possible in Taiwan’s evolving healthcare landscape.
With groundbreaking therapies and deep collaboration across Taiwan’s healthcare system, Novartis Taiwan is driving innovation, advancing equity, and building a healthier future.
